Saori Nishio

Dr. Saori Nishio


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Kidney International
Verified
Journal Article
Closed access
JYJunya Yamamoto
Junya Yamamoto
SNSaori Nishio
Saori Nishio
FHFumihiko Hattanda
Fumihiko Hattanda
DNDaigo Nakazawa
Daigo Nakazawa
TKToru Kimura
Toru Kimura
TATatsuya Atsumi
Tatsuya Atsumi

18 September 2014 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
HYHitoshi Yokoyama
Hitoshi Yokoyama
HSHitoshi Sugiyama
Hitoshi Sugiyama
NINarita Ichiei
Narita Ichiei
TSTakao Saito
Takao Saito
KYKunihiro Yamagata
Kunihiro Yamagata
SMSeiichi Matsuo
Seiichi Matsuo

8 August 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
SSSatoka Shiratori-Aso
Satoka Shiratori-Aso
DNDaigo Nakazawa
Daigo Nakazawa
TKTakashi Kudo
Takashi Kudo
MKMasatoshi Kanda
Masatoshi Kanda
YUYusho Ueda
Yusho Ueda
TATatsuya Atsumi
Tatsuya Atsumi
Neutrophil extracellular trap (NET) formation contributes to immune defense and is a distinct form of cell death. Excessive NET formation is found in patients with anti–neutrophil cytoplasmic antibody–associated (ANCA-associated) vasculitis (AAV), contributing to disease progression. The clearance of dead cells by macrophages, a process known as efferocytosis, is regulated by the CD47-mediated “don’t eat me” signal. Hence, we hypothesized that pathogenic NETs in AAV escape from efferocytosis via the CD47 signaling pathway, resulting in the development of necrotizing vasculitis. Immunostaining for CD47 in human renal tissues revealed high CD47 expression in crescentic glomerular lesions of patients with AAV. In ex vivo studies, ANCA-induced netting neutrophils increased the expression of CD47 with the reduction of efferocytosis. After efferocytosis, macrophages displayed proinflammatory phenotypes. The blockade of CD47 in spontaneous crescentic glomerulonephritis-forming/Kinjoh (SCG/Kj) mice ameliorated renal disease and reduced myeloperoxidase-ANCA (MPO-ANCA) titers with a reduction in NET formation. Thus, CD47 blockade would protect against developing glomerulonephritis in AAV via restored efferocytosis of ANCA-induced NETs.

3 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ASAKINARI SEKINE
AKINARI SEKINE
SHSumi Hidaka
Sumi Hidaka
TMTomofumi Moriyama
Tomofumi Moriyama
YSYasuto Shikida
Yasuto Shikida
KSKeiji Shimazu
Keiji Shimazu
SMSatoru Muto
Satoru Muto
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease, with patients often having a positive family history that is characterized by a similar phenotype. However, in atypical cases, particularly those in which family history is unclear, a differential diagnosis between ADPKD and other cystic kidney diseases is important. When diagnosing ADPKD, cystic kidney diseases that can easily be excluded using clinical information include: multiple simple renal cysts, acquired cystic kidney disease (ACKD), multilocular renal cyst/multilocular cystic nephroma/polycystic nephroma, multicystic kidney/multicystic dysplastic kidney (MCDK), and unilateral renal cystic disease (URCD). However, there are other cystic kidney diseases that usually require genetic testing, or another means of supplementing clinical information to enable a differential diagnosis of ADPKD. These include autosomal recessive polycystic kidney disease (ARPKD), autosomal dominant tubulointerstitial kidney disease (ADTKD), nephronophthisis (NPH), oral-facial-digital (OFD) syndrome type 1, and neoplastic cystic kidney disease, such as tuberous sclerosis (TSC) and Von Hippel-Lindau (VHL) syndrome. To help physicians evaluate cystic kidney diseases, this article provides a review of cystic kidney diseases for which a differential diagnosis is required for ADPKD.

25 November 2022 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
TKTakashi Kudo
Takashi Kudo
DNDaigo Nakazawa
Daigo Nakazawa
KWKanako Watanabe-Kusunoki
Kanako Watanabe-Kusunoki
MKMasatoshi Kanda
Masatoshi Kanda
SSSatoka Shiratori‐Aso
Satoka Shiratori‐Aso
TATatsuya Atsumi
Tatsuya Atsumi

12 June 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
STSayo Takeda
Sayo Takeda
KWKanako Watanabe-Kusunoki
Kanako Watanabe-Kusunoki
DNDaigo Nakazawa
Daigo Nakazawa
YKYoshihiro Kusunoki
Yoshihiro Kusunoki
SNSaori Nishio
Saori Nishio
TATatsuya Atsumi
Tatsuya Atsumi
Objective: ANCA associated vasculitis (AAV) is characterized by systemic necrotizing vasculitis with the presence of ANCA. Although BPI-ANCA is one of the atypical ANCAs and is occasionally seen in patients with vasculitis, the pathogenicity of BPI-ANCA remains unclear. This study was performed to examine the pathogenic role of BPI-ANCA against neutrophils. Methods: A 76-year-old Japanese man showed BPI-ANCA positive systemic vasculitis with a medical history of Pseudomonas aeruginosa infection. BPI-ANCA IgGs were eluted from the patient serum using an immunoadsorbent column. In vitro experiment, healthy donor neutrophils were treated with BPI-AAV IgGs, MPO-AAV IgGs, healthy control IgGs under TNFα stimulation. After 3 h incubation, neutrophil extracellular trap (NET) was assessed by immunofluorescent imaging. To determine the pathogenicity of BPI-ANCA, TNFα-primed neutrophils were incubated with monoclonal BPI-ANCA in the presence or absence of recombinant BPI. Results: BPI-AAV IgGs-treated neutrophils showed NET formation with histone citrullination. Interestingly, the monoclonal BPI-ANCA did not induce NET, but the immune complexes (ICs) of recombinant BPI and BPI-ANCA induced TNFα-dependent NET formation with hypercitrullination. Furthermore, TNFα increased the expression of BPIs in neutrophils and the BPIs were translocated to cell surface. Conclusion: BPI-ANCA could affect neutrophils leading to NET formation and may play a role in the development of systemic vasculitis as pathogenic autoantibody.